IBDEI02T ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3449,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,3450,0)
 ;;=283.19^^36^274^93
 ;;^UTILITY(U,$J,358.3,3450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3450,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,3450,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,3450,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,3451,0)
 ;;=280.9^^36^274^97
 ;;^UTILITY(U,$J,358.3,3451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3451,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,3451,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,3451,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,3452,0)
 ;;=285.1^^36^274^95
 ;;^UTILITY(U,$J,358.3,3452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3452,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,3452,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,3452,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,3453,0)
 ;;=280.0^^36^274^96
 ;;^UTILITY(U,$J,358.3,3453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3453,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,3453,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,3453,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,3454,0)
 ;;=281.9^^36^274^117
 ;;^UTILITY(U,$J,358.3,3454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3454,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,3454,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,3454,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,3455,0)
 ;;=281.0^^36^274^140
 ;;^UTILITY(U,$J,358.3,3455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3455,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,3455,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,3455,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,3456,0)
 ;;=282.60^^36^274^124
 ;;^UTILITY(U,$J,358.3,3456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3456,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,3456,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,3456,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,3457,0)
 ;;=282.62^^36^274^125
 ;;^UTILITY(U,$J,358.3,3457,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3457,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,3457,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,3457,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,3458,0)
 ;;=281.1^^36^274^141
 ;;^UTILITY(U,$J,358.3,3458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3458,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,3458,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,3458,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,3459,0)
 ;;=286.7^^36^274^64
 ;;^UTILITY(U,$J,358.3,3459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3459,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,3459,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,3459,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,3460,0)
 ;;=289.9^^36^274^137
 ;;^UTILITY(U,$J,358.3,3460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3460,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,3460,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,3460,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,3461,0)
 ;;=451.9^^36^274^138
 ;;^UTILITY(U,$J,358.3,3461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3461,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,3461,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,3461,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,3462,0)
 ;;=446.6^^36^274^139
 ;;^UTILITY(U,$J,358.3,3462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3462,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,3462,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,3462,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,3463,0)
 ;;=286.4^^36^274^143
 ;;^UTILITY(U,$J,358.3,3463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3463,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,3463,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,3463,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,3464,0)
 ;;=204.00^^36^274^17
 ;;^UTILITY(U,$J,358.3,3464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3464,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,3464,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,3464,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,3465,0)
 ;;=204.01^^36^274^16
 ;;^UTILITY(U,$J,358.3,3465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3465,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,3465,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,3465,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,3466,0)
 ;;=204.10^^36^274^61
 ;;^UTILITY(U,$J,358.3,3466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3466,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,3466,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,3466,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,3467,0)
 ;;=204.11^^36^274^60
 ;;^UTILITY(U,$J,358.3,3467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3467,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,3467,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,3467,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,3468,0)
 ;;=202.41^^36^274^87
 ;;^UTILITY(U,$J,358.3,3468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3468,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,3468,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,3468,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,3469,0)
 ;;=201.90^^36^274^94
 ;;^UTILITY(U,$J,358.3,3469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3469,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,3469,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,3469,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,3470,0)
 ;;=785.6^^36^274^101
 ;;^UTILITY(U,$J,358.3,3470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3470,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,3470,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,3470,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,3471,0)
 ;;=200.20^^36^274^102
 ;;^UTILITY(U,$J,358.3,3471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3471,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,3471,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,3471,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,3472,0)
 ;;=202.00^^36^274^104
 ;;^UTILITY(U,$J,358.3,3472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3472,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,3472,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3472,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,3473,0)
 ;;=200.10^^36^274^103
 ;;^UTILITY(U,$J,358.3,3473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3473,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,3473,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3473,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,3474,0)
 ;;=273.3^^36^274^105
 ;;^UTILITY(U,$J,358.3,3474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3474,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,3474,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,3474,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,3475,0)
 ;;=203.00^^36^274^115
 ;;^UTILITY(U,$J,358.3,3475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3475,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,3475,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,3475,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,3476,0)
 ;;=203.01^^36^274^114
 ;;^UTILITY(U,$J,358.3,3476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3476,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,3476,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,3476,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,3477,0)
 ;;=238.6^^36^274^118
 ;;^UTILITY(U,$J,358.3,3477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3477,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,3477,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,3477,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,3478,0)
 ;;=205.00^^36^274^19
 ;;^UTILITY(U,$J,358.3,3478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3478,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,3478,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3478,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,3479,0)
 ;;=205.01^^36^274^18
 ;;^UTILITY(U,$J,358.3,3479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3479,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,3479,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,3479,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,3480,0)
 ;;=205.10^^36^274^63
 ;;^UTILITY(U,$J,358.3,3480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3480,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,3480,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3480,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,3481,0)
 ;;=205.11^^36^274^62
 ;;^UTILITY(U,$J,358.3,3481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3481,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,3481,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,3481,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,3482,0)
 ;;=289.0^^36^274^65
 ;;^UTILITY(U,$J,358.3,3482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3482,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,3482,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,3482,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,3483,0)
 ;;=238.4^^36^274^119
 ;;^UTILITY(U,$J,358.3,3483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3483,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,3483,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,3483,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,3484,0)
 ;;=V58.61^^36^274^144
 ;;^UTILITY(U,$J,358.3,3484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3484,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,3484,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,3484,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,3485,0)
 ;;=282.49^^36^274^134
 ;;^UTILITY(U,$J,358.3,3485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3485,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,3485,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,3485,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,3486,0)
 ;;=289.89^^36^274^29
 ;;^UTILITY(U,$J,358.3,3486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3486,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,3486,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,3486,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,3487,0)
 ;;=238.79^^36^274^100
 ;;^UTILITY(U,$J,358.3,3487,1,0)
 ;;=^358.31IA^5^2
